mechlorethamine has been researched along with Cancer, Second Primary in 80 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine." | 9.08 | Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997) |
| "Colorectal cancer surveillance should be considered for HL survivors who received Infradiaphragmatic radiotherapy and a high cumulative procarbazine dose." | 7.85 | Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. ( Aleman, BM; de Boer, JP; De Bruin, ML; Janus, CP; Kremer, LC; Krol, AD; Louwman, MW; Schaapveld, M; van der Maazen, RW; van Eggermond, AM; van Leerdam, ME; van Leeuwen, FE; Visser, O; Zijlstra, JM, 2017) |
| "In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine." | 5.08 | Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997) |
| " The additional use of mechlorethamine or oral psoralen plus UV-A, but not radiation, was significantly associated with the development of basal cell carcinoma and squamous cell carcinoma, but not malignant melanoma." | 4.79 | Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation. ( Braverman, IM; Feldman, AM; Kacinski, BM; Licata, AG; Wilson, LD, 1995) |
| "Colorectal cancer surveillance should be considered for HL survivors who received Infradiaphragmatic radiotherapy and a high cumulative procarbazine dose." | 3.85 | Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. ( Aleman, BM; de Boer, JP; De Bruin, ML; Janus, CP; Kremer, LC; Krol, AD; Louwman, MW; Schaapveld, M; van der Maazen, RW; van Eggermond, AM; van Leerdam, ME; van Leeuwen, FE; Visser, O; Zijlstra, JM, 2017) |
| " We describe a 5-year-old boy with stage IV HD, successfully treated with MOPP (mechlorethamine, vincristine, procarbazine, and prednisone)/ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy followed by 35 Gy mantle radiotherapy who developed primary hyperparathyroidism because of benign PTA at the age of 20 years, and died of CS in thoracic vertebrae at the age of 22 years." | 3.76 | Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease. ( Albayrak, M; Coskun, U; Gursel, T; Kaya, Z; Keskin, EY; Kocak, U; Uluoglu, O, 2010) |
| "The cumulative dose of mechlorethamine was the most important factor in determining leukemia risk." | 3.69 | Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. ( Chorus, AM; Hagenbeek, A; Noyon, R; Pinedo, HM; Somers, R; van den Belt-Dusebout, AW; van Kerkhoff, EH; van Leeuwen, FE, 1994) |
| "Between 1978 and 1988, 20 children with medulloblastoma (MB) of the brain were treated postoperatively with MOPP (nitrogen mustard, vincristine, prednisone, and procarbazine)." | 3.68 | Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy. ( Hayani, A; Mahoney, DH; Taylor, LD, 1992) |
| "The causes of death were Hodgkin's lymphoma in 36 patients, second neoplasms in 12, cardiorespiratory diseases in 4, pulmonary diseases in 2, and unknown in 6." | 2.72 | MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors. ( Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F, 2006) |
| "In early-stage Hodgkin's lymphoma (HL), subtotal nodal irradiation (STNI) and combined chemotherapy/radiotherapy produce high disease control rates but also considerable late toxicity." | 2.72 | Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. ( Aleman, BM; Bosq, J; Carde, P; Dupouy, N; Eghbali, H; Girinsky, T; Hagenbeek, A; Henry-Amar, M; Kluin-Nelemans, JC; Krol, AD; Monconduit, M; Noordijk, EM; Pény, AM; Raemaekers, JM; Thomas, J; Tirelli, U; Verschueren, TA; Vovk, M, 2006) |
| "Two cases developed a second malignancy." | 2.68 | Treatment of childhood Hodgkin's disease without radiotherapy. ( Behrendt, H; van den Berg, H; Zsiros, J, 1997) |
| "80% or more of patients suffering from Hodgkin's lymphoma (HD) of limited stage are cured with modern treatment." | 2.39 | [Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults]. ( Glanzmann, C; Stahel, R, 1995) |
| "We reviewed all reported cases of Burkitt's lymphoma and/or Burkitt's leukemia (BLL) occurring following therapy for Hodgkin's disease." | 2.39 | Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease. ( Cooper, DL; Levy, A; Salloum, E; Tallini, G, 1996) |
| "Routine thyroid cancer screening may benefit females treated at a young age and ≥10 years from HL treatment owing to their higher risk, which increases over time." | 1.40 | Thyroid malignancies in survivors of Hodgkin lymphoma. ( Chen, YH; Marcus, KJ; Michaelson, EM; Ng, AK; Silver, B; Stevenson, MA; Tishler, RB, 2014) |
| "To assess therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS) risk in patients treated for Hodgkin lymphoma (HL) on successive generations of Stanford clinical trials." | 1.39 | Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials. ( Advani, RH; Balise, R; Greenberg, PL; Hoppe, RT; Horning, SJ; Koontz, MZ; Rosenberg, SA, 2013) |
| "Ductal invasive carcinoma and ductal carcinoma in situ represented, respectively, 51 cases (71%) and 14 cases (19%)." | 1.38 | Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option. ( Belin, L; Bollet, MA; Campana, F; Decaudin, D; Fourquet, A; Haberer, S; Kirova, YM; Le Scodan, R; Moisson, P; Pierga, JY; Reyal, F; Savignoni, A; Stevens, D, 2012) |
| "The behavior of Hodgkin's lymphoma (HL) is different in developing countries, perhaps due to differences in epidemiology and population access to health care." | 1.35 | Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. ( Alves, AC; Baiocchi, OC; Oliveira, JS; Souza, EM; Zanichelli, MA, 2009) |
| "The risk of stomach cancer was 3." | 1.35 | Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. ( Aleman, BM; Besseling, G; de Bruin, ML; de Wit, R; Gietema, JA; Hauptmann, M; Kerst, JM; Noordijk, EM; Ribot, JG; van 't Veer, MB; van den Belt-Dusebout, AW; van Leeuwen, FE, 2009) |
| "The treatment strategies of Hodgkin's lymphoma (HL) are different according to clinical stage and risk factors, yet the optimal treatment strategy remains unclear." | 1.34 | [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. ( Hu, DS; Hu, S; Song, QB; Tan, WY; Wei, L; Zeng, FY; Zhou, LQ, 2007) |
| "Actuarial risk of second malignancy for adolescents and adults was not different (P = ." | 1.33 | Hodgkin's lymphoma in adolescents. ( Connors, JM; Foltz, LM; Song, KW, 2006) |
| "We consider as second cancer all tumours other than HD observed in patients after treatment for HD." | 1.32 | [Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz]. ( Belhaj Ali, Z; Benna, F; Besbes, M; Bouaouina, N; Boussen, H; Gammoudi, A; Ghilen, L; Kochbati, L; Maalej, M; Rahal, K, 2003) |
| "Risk of lung cancer was borderline significantly greater in patients treated with mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy than those who did not receive this treatment (relative risk [RR] = 1." | 1.31 | Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. ( Allerton, R; Barber, JA; Cunningham, D; Horwich, A; Linch, DC; Lister, TA; Rohatiner, AZ; Schoemaker, MJ; Swerdlow, AJ; Vaughan Hudson, G; Williams, MV, 2001) |
| "The relative risk of second cancers overall was 27." | 1.30 | Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. ( Barber, JA; Cunningham, D; Horwich, A; Milan, S; Omar, RZ; Swerdlow, AJ, 1997) |
| "In this series, risk factors for second cancer were age >/=40 years (RR = 3." | 1.30 | Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. ( André, M; Attal, M; Bastion, Y; Blaise, D; Cahn, JY; Colombat, P; Fermé, C; Fleury, J; Gisselbrecht, C; Henry-Amar, M; Kuentz, M; Milpied, N; Nedellec, G; Pico, JL, 1998) |
| "Patients treated with radiotherapy for Hodgkin's disease have a considerable risk for a second cancer in long-term follow-up." | 1.30 | Second cancer among long-term survivors from Hodgkin's disease. ( Joensuu, H; Muhonen, T; Nyandoto, P, 1998) |
| "Risk of leukemia was 0." | 1.30 | The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con ( Anselmo, AP; Baroni, CD; Bernasconi, C; Brusamolino, E; Klersy, C; Lazzarino, M; Lunghi, F; Mandelli, F; Maurizi-Enrici, R; Orlandi, E; Pagnucco, G; Santoro, M, 1998) |
| "Hodgkin's disease is curable in the majority of patients, although a proportion of patients are resistant to or relapse after initial therapy." | 1.30 | High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. ( Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D, 1999) |
| "In patients with advanced Hodgkin's disease (HD), the alternation of MOPP with ABVD or hybrid MOPP/ABVD are associated with a high CR rate and a high probability of 5-year survival." | 1.29 | Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease. ( Aversa, S; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Mazzarotto, R; Pappagallo, GL; Salvagno, L; Scarzello, G; Sorarù, M; Sotti, G, 1995) |
| "The risk of second cancer was analyzed (1) relative to the general population and (2) between risk subgroups using the Cox proportional hazards model." | 1.29 | Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? ( Bodis, S; Bosq, J; Cosset, JM; Dietrich, PY; Hayat, M; Henry-Amar, M, 1994) |
| "Two cases of malignant schwannoma are reported 13 and 15 years following combined modality treatment for Hodgkin's disease." | 1.29 | Malignant schwannoma following treatment for Hodgkin's disease. ( Bridges, LR; Cartwright, SC; Dodwell, DJ; Fisher, PM; Stone, J, 1994) |
| "A case of Hodgkin's disease with isolated cerebral relapse is reported here." | 1.29 | Meningioma-like cerebral relapse of Hodgkin's disease. ( Catarini, M; Discepoli, G; Leoni, P; Montillo, M; Rychlicki, F; Scarpelli, M, 1994) |
| "Two patients developed breast cancer 14 and 8 years after treatment of Hodgkin's disease." | 1.29 | Breast cancer developing after therapy for Hodgkin's disease. ( Cascinu, S; Catalano, G; Fedeli, A, 1993) |
| "The occurrence of HIV associated non-Hodgkin's lymphoma (NHL) is a well recognized event." | 1.29 | Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient. ( Brody, J; Goh, JC; Kaplan, MH; Koduru, P; Lichtman, SM; Susin, M, 1993) |
| "We report a 54-year-old patient with Hodgkin's disease who achieved a complete remission after combined modality treatment." | 1.29 | Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease. ( Bendandi, M; Cantagalli, F; Macchi, S; Mancino, A; Simoncelli, F; Stefanati, V; Tura, S; Visani, G; Zaccaria, A; Zinzani, PL, 1995) |
| "Thirteen patients have died of their second malignancy, including two of a third malignancy, while four have been followed for less than one year." | 1.29 | Second malignant neoplasms in patients with Hodgkin's disease. ( Atkinson, CH; Colls, BM; Fitzharris, BM; Robinson, BA, 1994) |
| "A second neoplasm was found in 6 patients (6%), of whom 4 developed a myelodysplastic syndrome (MDS) and 2 a solid tumour." | 1.28 | [Second neoplasms as a late complication of the treatment of Hodgkin's disease]. ( Alvarez, A; Colomé, JA; del Potro, E; Díaz Mediavilla, J; González, FA; Martínez, R; Morales, MD; Villegas, A, 1992) |
| "20 untreated Hodgkin's disease patients and 1 patient relapsing after radiotherapy (17 stage IIB-IV and 4 stage I-IIA) were given doxorubicin, bleomycin, etoposide and prednisone on a 21-day cycle." | 1.28 | ABEP as primary chemotherapy for Hodgkin's disease. ( Alberto, P; Mermillod, B; Zulian, GB, 1992) |
| "These risks of second cancers are important in choice of treatment and in follow up of patients, but they are small compared with the great improvements in survival which have been brought about by modern therapeutic methods for Hodgkin's disease." | 1.28 | Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. ( Bennett, MH; Douglas, AJ; Hudson, BV; Hudson, GV; MacLennan, KA; Swerdlow, AJ, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (8.75) | 18.7374 |
| 1990's | 41 (51.25) | 18.2507 |
| 2000's | 21 (26.25) | 29.6817 |
| 2010's | 10 (12.50) | 24.3611 |
| 2020's | 1 (1.25) | 2.80 |
| Authors | Studies |
|---|---|
| Mou, E | 1 |
| Advani, RH | 2 |
| von Eyben, R | 1 |
| Rosenberg, SA | 2 |
| Hoppe, RT | 3 |
| van Eggermond, AM | 1 |
| Schaapveld, M | 1 |
| Janus, CP | 1 |
| de Boer, JP | 1 |
| Krol, AD | 2 |
| Zijlstra, JM | 1 |
| van der Maazen, RW | 3 |
| Kremer, LC | 1 |
| van Leerdam, ME | 1 |
| Louwman, MW | 1 |
| Visser, O | 1 |
| De Bruin, ML | 2 |
| Aleman, BM | 5 |
| van Leeuwen, FE | 3 |
| Lyons, AB | 1 |
| Mitchell, DA | 1 |
| Moy, RL | 2 |
| Lindahl, LM | 1 |
| Fenger-Grøn, M | 1 |
| Iversen, L | 1 |
| Michaelson, EM | 1 |
| Chen, YH | 1 |
| Silver, B | 1 |
| Tishler, RB | 1 |
| Marcus, KJ | 1 |
| Stevenson, MA | 1 |
| Ng, AK | 1 |
| Knobler, R | 1 |
| Almagro-Casado, E | 1 |
| Sánchez, A | 1 |
| Cantos, B | 1 |
| Salas, C | 1 |
| Pérez-Callejo, D | 1 |
| Provencio, M | 1 |
| Conway, JL | 1 |
| Connors, JM | 2 |
| Tyldesley, S | 1 |
| Savage, KJ | 1 |
| Campbell, BA | 1 |
| Zheng, YY | 1 |
| Hamm, J | 1 |
| Pickles, T | 1 |
| Mullah-Ali, A | 1 |
| Ramsay, JA | 1 |
| Bourgeois, JM | 1 |
| Hodson, I | 1 |
| Macdonald, P | 1 |
| Midia, M | 1 |
| Portwine, C | 1 |
| Souza, EM | 1 |
| Baiocchi, OC | 1 |
| Zanichelli, MA | 1 |
| Alves, AC | 1 |
| Oliveira, JS | 1 |
| van den Belt-Dusebout, AW | 2 |
| Besseling, G | 1 |
| Hauptmann, M | 1 |
| van 't Veer, MB | 2 |
| de Wit, R | 1 |
| Ribot, JG | 1 |
| Noordijk, EM | 2 |
| Kerst, JM | 1 |
| Gietema, JA | 1 |
| Keskin, EY | 1 |
| Gursel, T | 1 |
| Uluoglu, O | 1 |
| Albayrak, M | 1 |
| Kaya, Z | 1 |
| Coskun, U | 1 |
| Kocak, U | 1 |
| Haberer, S | 1 |
| Belin, L | 1 |
| Le Scodan, R | 1 |
| Kirova, YM | 1 |
| Savignoni, A | 1 |
| Stevens, D | 1 |
| Moisson, P | 1 |
| Decaudin, D | 1 |
| Pierga, JY | 1 |
| Reyal, F | 1 |
| Campana, F | 1 |
| Fourquet, A | 1 |
| Bollet, MA | 1 |
| Koontz, MZ | 1 |
| Horning, SJ | 1 |
| Balise, R | 1 |
| Greenberg, PL | 1 |
| Metayer, C | 1 |
| Curtis, RE | 1 |
| Vose, J | 1 |
| Sobocinski, KA | 1 |
| Horowitz, MM | 1 |
| Bhatia, S | 1 |
| Fay, JW | 1 |
| Freytes, CO | 1 |
| Goldstein, SC | 1 |
| Herzig, RH | 1 |
| Keating, A | 1 |
| Miller, CB | 1 |
| Nevill, TJ | 1 |
| Pecora, AL | 1 |
| Rizzo, JD | 1 |
| Williams, SF | 1 |
| Li, CY | 1 |
| Travis, LB | 2 |
| Weisdorf, DJ | 1 |
| Raemaekers, JM | 3 |
| Tirelli, U | 2 |
| Bortolus, R | 2 |
| Lybeert, ML | 2 |
| Keuning, JJ | 1 |
| Carde, P | 2 |
| Girinsky, T | 3 |
| Tomsic, R | 1 |
| Vovk, M | 2 |
| van Hoof, A | 1 |
| Demeestere, G | 2 |
| Lugtenburg, PJ | 1 |
| Thomas, J | 2 |
| Schroyens, W | 1 |
| De Boeck, K | 1 |
| Baars, JW | 1 |
| Kluin-Nelemans, JC | 2 |
| Carrie, C | 1 |
| Aoudjhane, M | 1 |
| Bron, D | 1 |
| Eghbali, H | 2 |
| Smit, WG | 1 |
| Meerwaldt, JH | 1 |
| Hagenbeek, A | 3 |
| Pinna, A | 2 |
| Henry-Amar, M | 5 |
| Longo, DL | 2 |
| KONDO, T | 2 |
| TSUKUI, K | 2 |
| LARIONOV, LF | 1 |
| LITVINOVA, EV | 1 |
| KHOLDIN, SA | 1 |
| SATO, H | 2 |
| KAWASHIMA, Y | 1 |
| KANNO, K | 1 |
| NEMETH, L | 1 |
| LAPIS, K | 1 |
| BIHARI, E | 1 |
| JAKOUBKOVA, J | 1 |
| PALECEK, L | 1 |
| Kochbati, L | 1 |
| Boussen, H | 1 |
| Benna, F | 1 |
| Belhaj Ali, Z | 1 |
| Gammoudi, A | 1 |
| Bouaouina, N | 1 |
| Besbes, M | 1 |
| Ghilen, L | 1 |
| Rahal, K | 1 |
| Maalej, M | 1 |
| Vassilakopoulos, TP | 1 |
| Angelopoulou, MK | 1 |
| Siakantaris, MP | 1 |
| Kontopidou, FN | 1 |
| Dimopoulou, MN | 1 |
| Kokoris, SI | 1 |
| Kyrtsonis, MC | 1 |
| Tsaftaridis, P | 1 |
| Karkantaris, C | 1 |
| Anargyrou, K | 1 |
| Boutsis, DE | 1 |
| Variamis, E | 1 |
| Michalopoulos, T | 1 |
| Boussiotis, VA | 1 |
| Panayiotidis, P | 1 |
| Papavassiliou, C | 1 |
| Pangalis, GA | 1 |
| Kneller, A | 1 |
| Cohen, N | 1 |
| Berkowicz, M | 1 |
| Reichart, M | 1 |
| Rosner, E | 1 |
| Sokolovski, M | 1 |
| Nagler, A | 1 |
| Rechavi, G | 1 |
| Amariglio, N | 1 |
| Trakhtenbrot, L | 1 |
| Bonadonna, G | 2 |
| Viviani, S | 2 |
| Bonfante, V | 2 |
| Gianni, AM | 1 |
| Valagussa, P | 2 |
| DeLair, SM | 1 |
| White, RW | 1 |
| Kurzrock, EA | 1 |
| Morbidini-Gaffney, S | 1 |
| Alpert, TE | 1 |
| Hatoum, GF | 1 |
| Sagerman, RH | 1 |
| Gobbi, PG | 1 |
| Broglia, C | 1 |
| Levis, A | 1 |
| La Sala, A | 1 |
| Valentino, F | 1 |
| Chisesi, T | 1 |
| Sacchi, S | 1 |
| Corbella, F | 1 |
| Cavanna, L | 1 |
| Iannitto, E | 1 |
| Pavone, V | 1 |
| Molica, S | 1 |
| Corazza, GR | 1 |
| Federico, M | 1 |
| Fermé, C | 2 |
| Mounier, N | 1 |
| Casasnovas, O | 1 |
| Brice, P | 1 |
| Divine, M | 1 |
| Sonet, A | 1 |
| Bouafia, F | 1 |
| Bastard-Stamatoullas, A | 1 |
| Bordessoule, D | 1 |
| Voillat, L | 1 |
| Reman, O | 1 |
| Blanc, M | 1 |
| Gisselbrecht, C | 2 |
| Foltz, LM | 1 |
| Song, KW | 1 |
| Dupouy, N | 1 |
| Monconduit, M | 1 |
| Bosq, J | 2 |
| Verschueren, TA | 1 |
| Pény, AM | 1 |
| Tomiŝiĉ, R | 1 |
| Baaijens, MH | 1 |
| Lugtenburg, P | 1 |
| Lievens, Y | 1 |
| de Jong, D | 1 |
| Diehl, V | 1 |
| Fuchs, M | 1 |
| Tan, WY | 1 |
| Hu, DS | 1 |
| Zeng, FY | 1 |
| Song, QB | 1 |
| Hu, S | 1 |
| Wei, L | 1 |
| Zhou, LQ | 1 |
| Glanzmann, C | 1 |
| Stahel, R | 1 |
| Brusamolino, E | 2 |
| Lazzarino, M | 2 |
| Orlandi, E | 2 |
| Canevari, A | 1 |
| Morra, E | 1 |
| Castelli, G | 1 |
| Alessandrino, EP | 1 |
| Pagnucco, G | 2 |
| Astori, C | 1 |
| Livraghi, A | 1 |
| Zanini, M | 1 |
| Santoro, A | 1 |
| Soncini, F | 1 |
| Devizzi, L | 1 |
| Villani, F | 1 |
| Castellani, MR | 1 |
| Negretti, E | 1 |
| Zucali, R | 1 |
| Salvagno, L | 1 |
| Sorarù, M | 1 |
| Sotti, G | 1 |
| Aversa, S | 1 |
| Chiarion Sileni, V | 1 |
| Mazzarotto, R | 1 |
| Scarzello, G | 1 |
| Bianco, A | 1 |
| Pappagallo, GL | 1 |
| Fiorentino, MV | 1 |
| Bendandi, M | 1 |
| Zaccaria, A | 1 |
| Zinzani, PL | 1 |
| Visani, G | 2 |
| Stefanati, V | 1 |
| Cantagalli, F | 1 |
| Mancino, A | 1 |
| Macchi, S | 1 |
| Simoncelli, F | 1 |
| Tura, S | 2 |
| Boice, JD | 1 |
| Lichtman, SM | 1 |
| Brody, J | 1 |
| Kaplan, MH | 1 |
| Susin, M | 1 |
| Koduru, P | 1 |
| Goh, JC | 1 |
| Licata, AG | 1 |
| Wilson, LD | 1 |
| Braverman, IM | 1 |
| Feldman, AM | 1 |
| Kacinski, BM | 1 |
| Rysenga, E | 1 |
| Linden, MD | 1 |
| Carey, JL | 1 |
| Ross, CW | 1 |
| Schnitzer, B | 1 |
| Sawdyk, M | 1 |
| Maeda, K | 1 |
| Montillo, M | 1 |
| Scarpelli, M | 1 |
| Discepoli, G | 1 |
| Catarini, M | 1 |
| Rychlicki, F | 1 |
| Leoni, P | 1 |
| Robinson, BA | 1 |
| Colls, BM | 1 |
| Fitzharris, BM | 1 |
| Atkinson, CH | 1 |
| Dietrich, PY | 1 |
| Cosset, JM | 1 |
| Bodis, S | 1 |
| Hayat, M | 1 |
| Smoller, BR | 1 |
| Marcus, R | 1 |
| Fisher, PM | 1 |
| Dodwell, DJ | 1 |
| Bridges, LR | 1 |
| Cartwright, SC | 1 |
| Stone, J | 1 |
| Chorus, AM | 1 |
| Noyon, R | 1 |
| van Kerkhoff, EH | 1 |
| Pinedo, HM | 1 |
| Somers, R | 1 |
| Cascinu, S | 1 |
| Fedeli, A | 1 |
| Catalano, G | 1 |
| Jenkin, D | 1 |
| Greenberg, M | 1 |
| Fitzgerald, A | 1 |
| Salloum, E | 1 |
| Tallini, G | 1 |
| Levy, A | 1 |
| Cooper, DL | 1 |
| Swerdlow, AJ | 3 |
| Barber, JA | 2 |
| Horwich, A | 2 |
| Cunningham, D | 2 |
| Milan, S | 1 |
| Omar, RZ | 1 |
| Redei, I | 1 |
| Mangan, KF | 1 |
| Ming, PL | 1 |
| Mullaney, MT | 1 |
| Rao, PN | 1 |
| Goldberg, SL | 1 |
| Klumpp, TR | 1 |
| van den Berg, H | 1 |
| Zsiros, J | 1 |
| Behrendt, H | 1 |
| Schellong, G | 1 |
| Riepenhausen, M | 1 |
| Creutzig, U | 1 |
| Ritter, J | 1 |
| Harbott, J | 1 |
| Mann, G | 1 |
| Gadner, H | 1 |
| Tsodikov, A | 1 |
| Loeffler, M | 1 |
| Yakovlev, A | 1 |
| Crowley, JJ | 1 |
| Nikko, A | 1 |
| Varghese, A | 1 |
| Kim, YH | 1 |
| Lamb, PM | 1 |
| Menaker, GM | 1 |
| Andrieu, JM | 1 |
| Colonna, P | 1 |
| André, M | 1 |
| Blaise, D | 1 |
| Colombat, P | 1 |
| Fleury, J | 1 |
| Milpied, N | 1 |
| Cahn, JY | 1 |
| Pico, JL | 1 |
| Bastion, Y | 1 |
| Kuentz, M | 1 |
| Nedellec, G | 1 |
| Attal, M | 1 |
| Arranz, R | 1 |
| Gil-Fernández, JJ | 1 |
| Muñoz, E | 1 |
| Acevedo, A | 1 |
| Sobrino, MP | 1 |
| Fernández-Rañada, JM | 1 |
| Nyandoto, P | 1 |
| Muhonen, T | 1 |
| Joensuu, H | 1 |
| Anselmo, AP | 1 |
| Klersy, C | 1 |
| Santoro, M | 1 |
| Lunghi, F | 1 |
| Maurizi-Enrici, R | 1 |
| Baroni, CD | 1 |
| Mandelli, F | 1 |
| Bernasconi, C | 1 |
| Aisenberg, AC | 1 |
| Lemoli, RM | 1 |
| Leopardi, G | 1 |
| Motta, MR | 1 |
| Rizzi, S | 1 |
| Testoni, N | 1 |
| Curti, A | 1 |
| Harrison, CN | 1 |
| Gregory, W | 1 |
| Hudson, GV | 2 |
| Devereux, S | 1 |
| Goldstone, AH | 1 |
| Hancock, B | 1 |
| Winfield, D | 1 |
| MacMillan, AK | 1 |
| Hoskin, P | 1 |
| Newland, AC | 1 |
| Milligan, D | 1 |
| Linch, DC | 2 |
| Schoemaker, MJ | 1 |
| Allerton, R | 1 |
| Lister, TA | 2 |
| Rohatiner, AZ | 1 |
| Vaughan Hudson, G | 1 |
| Williams, MV | 1 |
| Cellai, E | 1 |
| Magrini, SM | 1 |
| Masala, G | 1 |
| Alterini, R | 1 |
| Costantini, AS | 1 |
| Rigacci, L | 1 |
| Olmastroni, L | 1 |
| Papi, MG | 1 |
| Spediacci, MA | 1 |
| Innocenti, F | 1 |
| Bellesi, G | 1 |
| Ferrini, PR | 1 |
| Biti, G | 1 |
| Morales, MD | 1 |
| González, FA | 1 |
| Villegas, A | 1 |
| del Potro, E | 1 |
| Díaz Mediavilla, J | 1 |
| Martínez, R | 1 |
| Alvarez, A | 1 |
| Colomé, JA | 1 |
| Avilés, A | 1 |
| Díaz-Maqueo, JC | 1 |
| Ayala, JR | 1 |
| Cortés, HD | 1 |
| García, EL | 1 |
| Ganesan, TS | 1 |
| Oza, A | 1 |
| Perry, N | 1 |
| D'Ardenne, J | 1 |
| Arnott, S | 1 |
| Stansfeld, AG | 1 |
| Shand, WS | 1 |
| Wrigley, PF | 1 |
| Zulian, GB | 1 |
| Mermillod, B | 1 |
| Alberto, P | 1 |
| Douglas, AJ | 1 |
| Hudson, BV | 1 |
| Bennett, MH | 1 |
| MacLennan, KA | 1 |
| Hayani, A | 1 |
| Mahoney, DH | 1 |
| Taylor, LD | 1 |
| DeVita, VT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase III Randomized Trial of Adjuvant Involved-Field Radiotherapy vs No Adjuvant Therapy Following Remission Induction With MOPP/ABV Hybrid Chemotherapy in Patients With Stage III/IV Hodgkin's Disease[NCT00002462] | Phase 3 | 615 participants (Actual) | Interventional | 1989-09-30 | Active, not recruiting | ||
| Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial[NCT00924131] | 157 participants (Anticipated) | Observational | 2009-04-17 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for mechlorethamine and Cancer, Second Primary
| Article | Year |
|---|---|
Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 18; Chromosomes, Human, X; | 2008 |
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2007 |
[Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1995 |
Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Electrons; Female; Humans; Lymphoma, T | 1995 |
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide | 1996 |
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined | 1998 |
Problems in Hodgkin's disease management.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1999 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality | 1992 |
10 trials available for mechlorethamine and Cancer, Second Primary
| Article | Year |
|---|---|
Involved-field radiotherapy for advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2003 |
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Com | 2006 |
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1994 |
Treatment of childhood Hodgkin's disease without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1997 |
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child | 1997 |
Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxor | 1998 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality | 1992 |
63 other studies available for mechlorethamine and Cancer, Second Primary
| Article | Year |
|---|---|
Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Modality Therapy in the Stanford V Trials (the G4 and G5 Studies).
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Cyclophospham | 2021 |
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colon; Colo | 2017 |
Topical chemotherapy for numerous superficial basal cell carcinomas years after isolated limb perfusion for melanoma.
Topics: Administration, Cutaneous; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents | 2019 |
Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Cause of Death; Cohor | 2014 |
Thyroid malignancies in survivors of Hodgkin lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2014 |
Nitrogen mustard revisited.
Topics: Antineoplastic Agents, Alkylating; Female; Humans; Male; Mechlorethamine; Mycosis Fungoides; Neoplas | 2014 |
Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 2016 |
Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2017 |
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbaz | 2009 |
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cohort Studies; Combine | 2009 |
Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.
Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Chondrosarcoma | 2010 |
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms | 2012 |
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
Topics: Academic Medical Centers; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Californ | 2013 |
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemoth | 2003 |
Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chemotherapy, Adjuvant; | 2003 |
On production of metastases from rat tumor by nitrogen-mustard-N-oxide, x-ray, and cortisone.
Topics: Animals; Cortisone; Mechlorethamine; Mustard Plant; Neoplasms; Neoplasms, Experimental; Neoplasms, S | 1956 |
[Chemotherapy of mammary gland cancer metastases].
Topics: Breast; Breast Neoplasms; Humans; Mammary Glands, Human; Mechlorethamine; Neoplasms, Second Primary; | 1956 |
Experimental studies on the effects of nitromin upon tumor growth, with special respect to inhibition of metastasis production.
Topics: Animals; Mechlorethamine; Neoplasms; Neoplasms, Experimental; Neoplasms, Second Primary; Nitrogen Mu | 1957 |
[Effects of radiotherapy and chemotherapy on metastases of Guerin rat carcinoma].
Topics: Animals; Mannitol; Mechlorethamine; Neoplasms, Experimental; Neoplasms, Second Primary; Nitrogen Mus | 1959 |
[On the treatment of metastases of malignant epithelial tumors with chloralkylamine preparations].
Topics: Carcinoma; Mechlorethamine; Neoplasms, Second Primary; Nitrogen Mustard Compounds | 1959 |
Effects of nitrogen mustard N-oxide, x-rays, and cortisone on Yoshida sarcoma metastasis development.
Topics: Animals; Cortisone; Mechlorethamine; Neoplasms; Neoplasms, Second Primary; Nitrogen Mustard Compound | 1959 |
Experimental studies on the effects of nitromin (nitrogen mustard N-oxide) upon tumor growth, with special respect to inhibition of metastasis formation.
Topics: Animals; Mechlorethamine; Neoplasms; Neoplasms, Experimental; Neoplasms, Second Primary; Nitrogen Mu | 1959 |
[Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do | 2003 |
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera | 2004 |
Acquisition of a Ph chromosome with minor BCR/ABL fusion in treatment-related myelodysplastic syndrome with chromosome 7 abnormalities in a patient treated for Hodgkin disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Chromosome | 2005 |
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Dacarbazine; Disea | 2005 |
Secondary transitional cell carcinoma and nitrogen mustard treatment.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; Hodgkin Disease; Humans | 2005 |
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combin | 2005 |
Hodgkin's lymphoma in adolescents.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Chem | 2006 |
[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 2007 |
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combin | 1994 |
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1995 |
Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Transfusion; Combined Modality | 1995 |
Body wars: effect of friendly fire (cancer therapy)
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Hodgkin | 1995 |
Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dexametha | 1993 |
Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphocytes; Lymphoma, B-Ce | 1995 |
Meningioma-like cerebral relapse of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fatal Outcome; Female; Ho | 1994 |
Second malignant neoplasms in patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Moda | 1994 |
Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 1994 |
Risk of secondary cutaneous malignancies in patients with long-standing mycosis fungoides.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Follow-Up Studies; H | 1994 |
Malignant schwannoma following treatment for Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female | 1994 |
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Case-Co | 1994 |
Breast cancer developing after therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intr | 1993 |
Second malignant tumours in childhood Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Protocols; Cohort | 1996 |
Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 1997 |
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; An | 1997 |
A cure model with time-changing risk factor: an application to the analysis of secondary leukaemia. A report from the International Database on Hodgkin's Disease.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Fr | 1998 |
Mycosis fungoides in young patients: clinical characteristics and outcome.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Alkylating; Case-Control Studies; Cause of De | 1998 |
Multiple basal cell carcinomas of the limb after adjuvant treatment of melanoma with isolated limb perfusion.
Topics: Antineoplastic Agents, Alkylating; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Chemotherapy, Canc | 1998 |
Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hematopoietic Stem | 1998 |
Second cancer among long-term survivors from Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleom | 1998 |
Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1998 |
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con
Topics: Abdomen; Actuarial Analysis; Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; | 1998 |
Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Purging; Busulfan; Combined Mod | 1999 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; | 1999 |
Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Female; Hodgkin D | 2001 |
The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hosp
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; F | 2001 |
[Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 1992 |
Hodgkin's disease and acute leukemia. Is it a true association?
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil | 1992 |
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1992 |
ABEP as primary chemotherapy for Hodgkin's disease.
Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabin | 1992 |
Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
Topics: Adolescent; Adult; Alkylating Agents; Child; Chlorambucil; Cohort Studies; Female; Follow-Up Studies | 1992 |
Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool | 1992 |